Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer.

Molecular Cancer Therapeutics
Tadas S VasaitisAngela M H Brodie

Abstract

We previously reported that our novel compound 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene (VN/124-1) is a potent 17alpha-hydroxylase/17,20-lyase (CYP17) inhibitor/antiandrogen and strongly inhibits the formation and proliferation of human prostate cancer LAPC4 tumor xenografts in severe combined immunodeficient mice. In this study, we report that VN/124-1 and other novel CYP17 inhibitors also cause down-regulation of androgen receptor (AR) protein expression in vitro and in vivo. This mechanism of action seems to contribute to their antitumor efficacy. We compared the in vivo antitumor efficacy of VN/124-1 with that of castration and a clinically used antiandrogen, Casodex, and show that VN/124-1 is more potent than castration in the LAPC4 xenograft model. Treatment with VN/124-1 (0.13 mmol/kg twice daily) was also very effective in preventing the formation of LAPC4 tumors (6.94 versus 2410.28 mm(3) in control group). VN/124-1 (0.13 mmol/kg twice daily) and VN/124-1 (0.13 mmol/kg twice daily) + castration induced regression of LAPC4 tumor xenografts by 26.55% and 60.67%, respectively. Treatments with Casodex (0.13 mmol/kg twice daily) or castration caused significant tumor suppression compared with control. Fur...Continue Reading

References

Jan 1, 1991·The Journal of Steroid Biochemistry and Molecular Biology·P F Hall
Aug 17, 1989·The New England Journal of Medicine·E D CrawfordP J Goodman
Jul 1, 1983·The Journal of Urology·J TrachtenbergA Pont
May 25, 1995·The New England Journal of Medicine·M E TaplinS P Balk
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·S YehC Chang
Nov 22, 2001·Journal of the National Cancer Institute·M E GrossmannD J Tindall
Mar 20, 2002·Nature Reviews. Cancer·B J Feldman, D Feldman
Jul 12, 2002·Archiv der Pharmazie·Rolf W HartmannYan Zhuang
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Karine SteketeeJan Trapman
Jan 2, 2004·Nature Medicine·Charlie D ChenCharles L Sawyers
Nov 24, 2004·The Journal of Steroid Biochemistry and Molecular Biology·Venkatesh D HandrattaAngela M H Brodie
Mar 23, 2005·Cancer Research·Tai-Lung ChaMien-Chie Hung
Apr 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Casey E BohlJames T Dalton
Jul 19, 2005·Current Medicinal Chemistry·F Leroux
Jan 24, 2006·Pharmacology & Therapeutics·Tarek Hakki, Rita Bernhardt
Mar 4, 2006·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 19, 2006·Cellular & Molecular Biology Letters·Tomasz Jaworski
Mar 28, 2007·Prostate Cancer and Prostatic Diseases·K SuzukiF Labrie
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun

❮ Previous
Next ❯

Citations

Nov 25, 2011·Der Urologe. Ausg. A·C-H OhlmannM Stöckle
Apr 28, 2012·Current Treatment Options in Oncology·Won Kim, Charles J Ryan
Feb 10, 2009·Nature Clinical Practice. Urology·William P HarrisBruce Montgomery
May 18, 2011·Prostate Cancer and Prostatic Diseases·E S Antonarakis, A J Armstrong
Dec 17, 2011·The Journal of Biological Chemistry·Harris S SoiferCy A Stein
Feb 14, 2012·Current Opinion in Oncology·Kevin D Courtney, Mary-Ellen Taplin
Feb 27, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity·Trevor M Penning
Mar 18, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hollie I SwansonEmily E Scott
Nov 24, 2011·Prostate Cancer·Abhijit M Godbole, Vincent C O Njar
Jul 30, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Karen E Knudsen, Howard I Scher
Jul 25, 2013·International Journal of Molecular Sciences·Lina YinRolf W Hartmann
Mar 24, 2011·Future Medicinal Chemistry·Tadas S Vasaitis, Vincent C O Njar
Apr 11, 2013·International Journal of Cell Biology·Jennifer H GunterColleen C Nelson
Jul 3, 2013·Prostate Cancer·Jesal C PatelNeeraj Agarwal
May 21, 2014·Nature Reviews. Clinical Oncology·Yien Ning Sophia WongJohann de Bono
Apr 25, 2014·Asian Journal of Andrology·Mark N SteinEric A Singer
May 16, 2014·Endocrine-related Cancer·Trevor M Penning
Jan 7, 2014·Cancer Metastasis Reviews·Joaquin MateoJohann S de Bono
Jan 5, 2014·Cancer Metastasis Reviews·Zoran Culig, Frédéric R Santer
Mar 19, 2014·Endocrine-related Cancer·Christine HelsenFrank Claessens
Oct 31, 2015·Expert Opinion on Therapeutic Patents·Richard L SchroederJayalakshmi Sridhar
Mar 26, 2014·Expert Opinion on Therapeutic Patents·Sheena Francis, Rupika Delgoda
Mar 6, 2012·Expert Review of Endocrinology & Metabolism·Karen E Knudsen, William Kevin Kelly
Jun 15, 2014·Expert Review of Anticancer Therapy·David D ChismYoung E Whang
Jun 13, 2015·Expert Opinion on Pharmacotherapy·Benjamin L Maughan, Emmanuel S Antonarakis
Jun 8, 2010·Expert Opinion on Investigational Drugs·Nima Sharifi
Nov 28, 2013·Expert Opinion on Emerging Drugs·Paul H ChungGanesh V Raj
Jun 29, 2013·Seminars in Oncology·Jean Hoffman-Censits, Maofu Fu
Jun 29, 2013·Seminars in Oncology·Phillip L Palmbos, Maha Hussain
Sep 4, 2015·Clinical Pharmacology and Therapeutics·Daniel J CronaYoung E Whang
Oct 1, 2011·Clinical Genitourinary Cancer·Mari NakabayashiMary-Ellen Taplin
Sep 6, 2011·Endocrinology and Metabolism Clinics of North America·Elahe A Mostaghel, Stephen Plymate
Jan 16, 2015·Journal of Medicinal Chemistry·Vincent C O Njar, Angela M H Brodie
Jan 6, 2016·Hormones & Cancer·Christopher Foley, Nicholas Mitsiades
Jul 1, 2010·Drug Discovery Today. Therapeutic Strategies·Jeanny B Aragon-Ching, William L Dahut
Nov 26, 2010·The Journal of Steroid Biochemistry and Molecular Biology·Tadas S VasaitisVincent C O Njar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.